Clinical predictors of antidepressant response to ketamine in unipolar treatment-resistant depression

被引：2
|
作者：
Del Sant, L. C. [1 ]
Magalhaes, E. [1 ]
Lucchese, A. C. [1 ]
Palhares Alves, H. N. [1 ]
Sarin, L. M. [1 ]
Del Porto, J. A. [1 ]
Tavares de lacerda, A. L. [1 ]
机构：
[1] Univ Fed Sao Paulo, Psychiat, Sao Paulo, Brazil
来源：
EUROPEAN PSYCHIATRY | 2017年 / 41卷
关键词：
D O I：
10.1016/j.eurpsy.2017.01.704
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EV0374
引用
收藏
页码：S525 / S526
页数：2
相关论文
共 50 条
  • [31] Ketamine for Treatment-Resistant Depression: Ready or Not for Clinical Use?
    Rush, A. John
    AMERICAN JOURNAL OF PSYCHIATRY, 2013, 170 (10): : 1079 - 1081
  • [32] KETAMINE FOR TREATMENT-RESISTANT DEPRESSION: READY FOR CLINICAL TRANSLATION?
    Loo, C. K.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2023, 57 (01): : 10 - 10
  • [33] Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment-resistant depression
    Jesus-Nunes, Ana Paula
    Leal, Gustavo C.
    Correia-Melo, Fernanda S.
    Vieira, Flavia
    Mello, Rodrigo P.
    Caliman-Fontes, Ana Teresa
    Echegaray, Mariana V. F.
    Marback, Roberta F.
    Guerreiro-Costa, Livia N. F.
    Souza-Marques, Breno
    Santos-Lima, Cassio
    Souza, Lucca S.
    Bandeira, Igor D.
    Kapczinski, Flavio
    Lacerda, Acioly L. T.
    Quarantini, Lucas C.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2022, 37 (04)
  • [34] Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression
    Salloum, Naji C.
    Fava, Maurizio
    Freeman, Marlene P.
    Flynn, Martina
    Hoeppner, Bettina
    Hock, Rebecca S.
    Cusin, Cristina
    Iosifescu, Dan V.
    Trivedi, Madhukar H.
    Sanacora, Gerard
    Mathew, Sanjay J.
    Debattista, Charles
    Ionescu, Dawn F.
    Papakostas, George I.
    DEPRESSION AND ANXIETY, 2019, 36 (03) : 235 - 243
  • [35] Biomarkers of the rapid clinical response to ketamine in treatment-resistant depression: focus on kynurenine
    Clarke, G.
    Naughton, M.
    O'Shea, R.
    Dowling, J.
    Walsh, A.
    Ismail, F.
    Shorten, G.
    Scott, L.
    Cryan, J. F.
    Dinan, T. G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S460 - S460
  • [36] VENLAFAXINE FOR TREATMENT-RESISTANT UNIPOLAR DEPRESSION
    NIERENBERG, AA
    FEIGHNER, JP
    RUDOLPH, R
    COLE, JO
    SULLIVAN, J
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1994, 14 (06) : 419 - 423
  • [37] Inflammation Moderates Antidepressant Response to Ketamine in a Rodent Model of Treatment-Resistant Depression: Bioenergetic and Inflammatory Markers of Response
    Tye, Susannah
    Price, J. Blair
    Walker, Adam
    Kruse, Jennifer
    Cullen, Kathryn
    Frye, Mark
    Schwieler, Lilly
    Erhardt, Sophie
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 277 - 277
  • [38] Inflammation Moderates Antidepressant Response to Ketamine in a Rodent Model of Treatment-Resistant Depression: Bioenergetic and Inflammatory Markers of Response
    Tye, Susannah
    Price, J. Blair
    Walker, Adam
    Kruse, Jennifer
    Cullen, Kathryn
    Frye, Mark
    Schwieler, Lilly
    Erhardt, Sophie
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 277 - 277
  • [39] Innovations in treatment of treatment-resistant unipolar depression
    Ebrinc, Servet
    JOURNAL OF MOOD DISORDERS, 2013, 3 : S51 - S53
  • [40] Neurocognitive Effects of Ketamine and Association with Antidepressant Response in Individuals with Treatment-Resistant Depression: A Randomized Controlled Trial
    Murrough, James W.
    Burdick, Katherine E.
    Levitch, Cara F.
    Perez, Andrew M.
    Brallier, Jess W.
    Chang, Lee C.
    Foulkes, Alexandra
    Charney, Dennis S.
    Mathew, Sanjay J.
    Iosifescu, Dan V.
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 (05) : 1084 - 1090
12345